SMMT icon

Summit Therapeutics
SMMT

Overview Fund Activity

123 hedge funds and large institutions have $563M invested in Summit Therapeutics in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 20 increasing their positions, 47 reducing their positions, and 21 closing their positions.

Holders
123
Holders Change
+18
Holders Change %
+17.14%
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
41
Increased
20
Reduced
47
Closed
21
Calls
$13.8M
Puts
$9.02M
Net Calls
+$4.74M
Net Calls Change
+$4.03M

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$181M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$15.9M
3
Millennium Management
3
Millennium Management
New York
$15.2M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$68.8M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$7.88M

Top Sellers

1
State Street
1
State Street
Massachusetts
$32.2M
2
BlackRock
2
BlackRock
New York
$61.6M
3
Citigroup
3
Citigroup
New York
$496K
4
Rafferty Asset Management
4
Rafferty Asset Management
New York
$1.29M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$59M
Name Market Value Shares Shares
Change 		Shares
Change %
Carson Wealth (CWM LLC)
151
Carson Wealth (CWM LLC)
Nebraska
$0 11 +5 +83%
3 4 5 6
7